Viatris' RYZUMVI (phentolamine ophthalmic solution) receives FDA approval to treat presbyopia in adults

Viatris received FDA approval for RYZUMVI (phentolamine ophthalmic solution 0.75%) to treat presbyopia in adults.

Detected & updated continuously · Source: Nebula

Story subjects

Opus Genetics, Inc.Food and Drug Administration

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula